TY  - RPRT
TI  - Targeting LDHC dysregulates the cell cycle and improves sensitivity to cisplatin and olaparib
AU  - Naik, A.
AU  - Decock, J.
PY  - 2021
DO  - 10.1101/2021.03.03.433525
UR  - https://www.biorxiv.org/content/10.1101/2021.03.03.433525v1
ID  - 10.1101/2021.03.03.433525
ER  -